What next after shortened TB treatment fails in key trial?

Spotlight reflected on the results from two TB trials - SimpliciTB and TRUNCATE-TB, reported at the 30th Conference on Retroviruses and Opportunistic Infections (CROI 2023) held on 19-22 February 2023 in Seattle, Washington, USA, featuring TAG TB Co-Director Lindsay McKenna, elaborating on what comes next as an alternative to the six-month drug-susceptible standard of TB care.

Read the full article here.

To subscribe to the Weekly Newsletter of new posts, enter your email here:


By Elri Voigt

Published: Feb. 27, 2023, 10:26 p.m.

Last updated: March 6, 2023, 10:28 p.m.

Print Share